Related Experiment Videos
Diagnosis and management of cholestatic liver disease
1University Health Network, University of Toronto, Hepatology, Toronto, Ontario, Canada. jenny.heathcote@utoronto.ca
Insights
Cholestasis, a condition of slowed bile flow, can be acute or chronic. Early diagnosis and management, including ursodeoxycholic acid and liver transplant, are key for improving outcomes and preventing complications like osteoporosis.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Cholestasis, characterized by slowed bile flow, presents acutely or chronically across all age groups.
- Congenital and inherited factors are common causes in pediatric populations, with improved management enabling survival into adulthood.
- Jaundice, while a hallmark, may be absent in adults with asymptomatic chronic cholestatic liver disease.
Purpose of the Study:
- To provide a comprehensive overview of cholestasis, encompassing its diverse causes, diagnostic approaches, and therapeutic strategies.
- To highlight the importance of early diagnosis and management in both pediatric and adult cholestasis.
- To discuss the potential complications and long-term consequences of cholestasis, including portal hypertension and bone disease.
Main Methods:
- Review of clinical presentation, diagnostic modalities, and therapeutic interventions for cholestasis.
- Emphasis on the role of detailed patient history, physical examination, and noninvasive radiologic tests (ultrasound, CT, MRI cholangiography).
- Evaluation of liver biopsy findings, particularly portal tract assessment for small bile duct damage.
Main Results:
- Noninvasive radiologic imaging significantly aids in diagnosing cholestasis, especially when extrahepatic.
- Liver biopsy is reliable for evaluating small bile duct damage only with adequate portal tracts (>10).
- Ursodeoxycholic acid demonstrates efficacy in improving biochemical markers and potentially delaying disease progression.
Conclusions:
- Therapeutic strategies must address the underlying cause of cholestasis and manage consequences like retained bile acids and gastrointestinal bile delivery issues.
- Symptomatic treatment, primarily for pruritus, and prevention of complications such as osteoporosis are crucial.
- While ursodeoxycholic acid offers benefits, liver transplantation remains the only potentially curative option for advanced cholestatic liver disease.
Abstract:
Cholestasis (slowing of bile flow) may be acute or chronic and affect any age group. In infants and children the causes often are congenital or inherited and as a result of improved management some affected children now survive to adulthood. Although jaundice is a hallmark of cholestasis it may be absent, particularly in adults with chronic cholestatic liver disease most of whom are entirely asymptomatic. A detailed history and physical are crucial to the diagnosis and noninvasive radiologic tests (ultrasound, computerized tomography scan, and magnetic resonance cholangiography) greatly facilitate diagnosis, particularly when the cause is extrahepatic. Only if sufficient portal tracts (>10) are present on liver biopsy examination can this test reliably evaluate damage to the small bile ducts. Therapy should address both the cause and the consequences of retained bile acids within the liver, and diminished delivery of bile to the gastrointestinal tract. Therapies should address symptoms, mostly pruritus and prevention, particularly osteoporosis and osteomalacia. Portal hypertension can be an early event in chronic cholestatic liver disease, sometimes occurring before the development of cirrhosis. Ursodeoxycholic acid improves the biochemical markers of cholestasis regardless of cause and may delay liver disease progression; only liver transplant is potentially curative.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:20Cholecystitis
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow